Newsmax TV & Webwww.newsmax.comFREE - In Google Play
Newsmax TV & Webwww.newsmax.comFREE - On the App Store

New Drug Increases Lung Cancer Survival

Tuesday, 27 September 2011 11:35 AM EDT

Patients with terminal lung cancer lived four times longer than doctors expected when given a new drug. MetMAb increased the survival time of cancer victims from three months to more than a year.

A clinical trial looked at cancer patients who were out of options — their cancer had spread and they were no longer responding to other treatments. When MetMAb was added to the cancer drug Tarceva, survival time increased dramatically.

The drug works in patients whose cancer cells contain high levels of a protein called MET, which causes cancer cells to grow and spread more rapidly.

© HealthDay

Tuesday, 27 September 2011 11:35 AM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
You May Also Like
Get Newsmax Text Alerts

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

© Newsmax Media, Inc.
All Rights Reserved
© Newsmax Media, Inc.
All Rights Reserved